SEPTEMBER 10, 2020
Grants Awarded

Extramurally funded research grants awarded to Rogel Cancer Center members

Program Key:
CB - Cancer Biology; CG - Cancer Genetics; CHI - Cancer Hematopoiesis and Immunology; DT - Developmental Therapeutics; HBO - Health Behavior and Outcomes; CEP - Cancer Epidemiology and Prevention; TACR - Translational and Clinical Research
Rogel Cancer Center List of Internal and External Funding Opportunities
We update and maintain a comprehensive list of funding opportunities for cancer research.

In the spotlight
From Cancer Epidemiology and Prevention
A multi-PI, intra-programmatic, $7.2 million UG1 grant was awarded by the National Cancer Institute (NCI) to Dean Brenner, M.D., and Zora Djuric, Ph.D., for “Early Phase Clinical Cancer Prevention Consortium."
From Health Behavior and Health Outcomes
The NCI awarded Steven Katz, M.D., M.P.H., Larry An, M.D., and Allison Kurian, M.D., M.Sc. (Stanford), with a $3.7 million multi-PI, intra-programmatic, multi-institutional Biden Moonshot U01 grant for “A Population-based Virtual Solution to Reduce Gaps in Genetic Risk Evaluation and Management in Families at High Risk for Hereditary Cancer Syndromes: The Georgia-California GeneLINK Trial.”
From Cancer Biology, Cancer Epidemiology and Prevention, and Cancer Genetics
A multi-PI, inter-programmatic, $2.9 million R01 grant was awarded by the NCI to Nisha D’Silva, D.D.S., Laura Rozek, Ph.D., and Maureen Sartor, Ph.D., for “Downstream Effects of HPV Integration on Survival/Metastasis in Oropharyngeal Cancer.”
Other $100K+ Extramural Grants Awarded in July
NCI

Evan Keller, D.V.M., Ph.D.: P01 Renewal ($7.4M) “The Biology of Prostate Cancer Skeletal Metastases” (CB)

Joshi Alumkal, M.D.: R01 ($2M) “Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition” (DT)

Leslie Parsels, Ph.D. (Unit Director: Theodore Lawrence, M.D., Ph.D., FASTRO, FASCO): R50 ($719K) “Improving the Therapeutic Efficacy of Chemoradiation by Targeting the DNA Damage Response” (TACR)

Muneesh Tewari, M.D., Ph.D., Nils Walter, Ph.D., and Alexander Johnson-Buck, Ph.D.: R21 ($609K) “Highly Specific, Amplification-free, Single-molecule Counting of Rare Methylated DNA Cancer Biomarkers” (TACR)

Arul Chinnaiyan, M.D., Ph.D.: P30 Supplement ($390K) “Covid-19 Targeting TMPRSS2 Expression as a Therapy for Coronavirus Infection and Replication” (CG/TACR)


Other NIH

Rajesh Rao, M.D.: NEI R01 ($2M) “Molecular Determinants for WDR5-Driven Transcriptional Regulation at Lineage-Specifying Genes During Retinogenesis” (CG)

Other External

David Lipps, Ph.D.: $787K American Cancer Society, Research Scholar Grant for “Quantifying Outcomes after Prepectoral Implant-Based Breast Reconstruction” (HBO)

David Lombard, M.D., Ph.D.: $623K Department of Defense, Peer Reviewed Cancer Research Program Idea Award with Special Focus for “A Novel Strategy to Target the EWS-FLI1 Oncoprotein in Ewing Sarcoma” (CG)

Breast Cancer Research Foundation Award Renewals: Debra Barton, Ph.D., R.N., Lori Pierce, M.D., Max Wicha, M.D., Sofia Merajver, M.D., Ph.D., and James Rae, Ph.D. (HBO, TACR, CB)
Please forward this message to your fellow cancer center colleagues.
M-LINE 800-962-3555 | BLOG michiganhealthlab.org